## **Core Concept**
Prophylactic chemotherapy in the context of hydatidiform mole is considered to prevent the development of gestational trophoblastic neoplasia (GTN), a malignant condition that can arise from molar pregnancies. The goal is to reduce the risk of progression to GTN. **Chemotherapy** is used here as a preventive measure in high-risk cases.

## **Why the Correct Answer is Right**
The correct answer, **Methotrexate**, is a chemotherapeutic agent that is commonly used in the treatment and prophylaxis of gestational trophoblastic disease, including high-risk hydatidiform moles. Methotrexate works by inhibiting dihydrofolate reductase, an enzyme critical for DNA synthesis and cell replication, thereby exerting its cytotoxic effects on rapidly dividing cells, such as those found in trophoblastic diseases. Its use in prophylaxis is considered in cases with high-risk features to prevent the development of GTN.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is blank and cannot be evaluated.
- **Option B:** This option is blank and cannot be evaluated.
- **Option C:** This option is blank and cannot be evaluated.
- **Option D:** This option is blank and cannot be evaluated.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that not all patients with hydatidiform mole require prophylactic chemotherapy; it is generally reserved for those with high-risk features, such as a large uterine size for dates, high levels of beta-hCG, and the presence of metastases. **The use of prophylactic chemotherapy must be balanced against potential side effects and the individual patient's risk profile.**

## **Correct Answer Line**
**Correct Answer: B. Methotrexate**